CRL
Price
$163.99
Change
+$1.68 (+1.04%)
Updated
Sep 5 closing price
Capitalization
8.07B
53 days until earnings call
ESLOY
Price
$152.42
Change
+$0.20 (+0.13%)
Updated
Sep 5 closing price
Capitalization
139.91B
40 days until earnings call
Interact to see
Advertisement

CRL vs ESLOY

Header iconCRL vs ESLOY Comparison
Open Charts CRL vs ESLOYBanner chart's image
Charles River Laboratories International
Price$163.99
Change+$1.68 (+1.04%)
Volume$598.96K
Capitalization8.07B
EssilorLuxottica
Price$152.42
Change+$0.20 (+0.13%)
Volume$30.31K
Capitalization139.91B
CRL vs ESLOY Comparison Chart in %
Loading...
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRL vs. ESLOY commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a Buy and ESLOY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CRL: $163.99 vs. ESLOY: $152.42)
Brand notoriety: CRL and ESLOY are both not notable
CRL represents the Medical Specialties, while ESLOY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CRL: 70% vs. ESLOY: 31%
Market capitalization -- CRL: $8.07B vs. ESLOY: $139.91B
CRL [@Medical Specialties] is valued at $8.07B. ESLOY’s [@Pharmaceuticals: Other] market capitalization is $139.91B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.68B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 1 FA rating(s) are green whileESLOY’s FA Score has 3 green FA rating(s).

  • CRL’s FA Score: 1 green, 4 red.
  • ESLOY’s FA Score: 3 green, 2 red.
According to our system of comparison, ESLOY is a better buy in the long-term than CRL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 6 TA indicator(s) are bullish while ESLOY’s TA Score has 3 bullish TA indicator(s).

  • CRL’s TA Score: 6 bullish, 2 bearish.
  • ESLOY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CRL is a better buy in the short-term than ESLOY.

Price Growth

CRL (@Medical Specialties) experienced а +0.42% price change this week, while ESLOY (@Pharmaceuticals: Other) price change was -0.05% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.01%. For the same industry, the average monthly price growth was +8.25%, and the average quarterly price growth was +13.64%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Reported Earning Dates

CRL is expected to report earnings on Oct 29, 2025.

ESLOY is expected to report earnings on Oct 16, 2025.

Industries' Descriptions

@Medical Specialties (+1.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESLOY($140B) has a higher market cap than CRL($8.07B). CRL has higher P/E ratio than ESLOY: CRL (577.05) vs ESLOY (50.82). ESLOY YTD gains are higher at: 30.529 vs. CRL (-11.165). ESLOY has higher annual earnings (EBITDA): 6.71B vs. CRL (528M). ESLOY has more cash in the bank: 3.16B vs. CRL (183M). CRL has less debt than ESLOY: CRL (2.79B) vs ESLOY (14B). ESLOY has higher revenues than CRL: ESLOY (27.2B) vs CRL (4.03B).
CRLESLOYCRL / ESLOY
Capitalization8.07B140B6%
EBITDA528M6.71B8%
Gain YTD-11.16530.529-37%
P/E Ratio577.0550.821,136%
Revenue4.03B27.2B15%
Total Cash183M3.16B6%
Total Debt2.79B14B20%
FUNDAMENTALS RATINGS
CRL vs ESLOY: Fundamental Ratings
CRL
ESLOY
OUTLOOK RATING
1..100
1872
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
10015
SMR RATING
1..100
9295
PRICE GROWTH RATING
1..100
5949
P/E GROWTH RATING
1..100
130
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESLOY's Valuation (33) in the null industry is somewhat better than the same rating for CRL (92) in the Miscellaneous Commercial Services industry. This means that ESLOY’s stock grew somewhat faster than CRL’s over the last 12 months.

ESLOY's Profit vs Risk Rating (15) in the null industry is significantly better than the same rating for CRL (100) in the Miscellaneous Commercial Services industry. This means that ESLOY’s stock grew significantly faster than CRL’s over the last 12 months.

CRL's SMR Rating (92) in the Miscellaneous Commercial Services industry is in the same range as ESLOY (95) in the null industry. This means that CRL’s stock grew similarly to ESLOY’s over the last 12 months.

ESLOY's Price Growth Rating (49) in the null industry is in the same range as CRL (59) in the Miscellaneous Commercial Services industry. This means that ESLOY’s stock grew similarly to CRL’s over the last 12 months.

CRL's P/E Growth Rating (1) in the Miscellaneous Commercial Services industry is in the same range as ESLOY (30) in the null industry. This means that CRL’s stock grew similarly to ESLOY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLESLOY
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
61%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
43%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
53%
Advances
ODDS (%)
Bullish Trend 9 days ago
69%
Bullish Trend 2 days ago
60%
Declines
ODDS (%)
Bearish Trend 11 days ago
69%
Bearish Trend 5 days ago
50%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
40%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
46%
View a ticker or compare two or three
Interact to see
Advertisement
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNFPX71.47N/A
N/A
American Funds New Perspective 529-F-3
FDEGX76.57N/A
N/A
Fidelity Growth Strategies
IBBFX14.64N/A
N/A
Thrivent Dynamic Allocation S
CPECX21.07N/A
N/A
Catalyst Dynamic Alpha C
VYCFX26.45N/A
N/A
Voya Corporate Leaders 100 R

ESLOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESLOY has been loosely correlated with ESLOF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOY jumps, then ESLOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLOY
1D Price
Change %
ESLOY100%
+0.13%
ESLOF - ESLOY
58%
Loosely correlated
-2.34%
QGEN - ESLOY
43%
Loosely correlated
+1.08%
ALC - ESLOY
38%
Loosely correlated
+1.60%
SMMNY - ESLOY
38%
Loosely correlated
+0.80%
CRL - ESLOY
35%
Loosely correlated
+1.04%
More